The small-molecule compounds called Smac mimetics were designed to mimic the inhibition of IAPs, antagonise their function and induce TNF-dependent cell death.11 Multiple clinical cancer trials validated the therapeutic applicability of Smac mimetics to induce targeted TNF-mediated death of tumour cells. The gene discussed is TNF; the disease is neoplasm.